Related Experiment Video
Updated: Jan 26, 2026

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
Published on: March 14, 2019
Emerging microRNA biomarkers for colorectal cancer diagnosis and prognosis
Bing Chen1,2, Zijing Xia1,3, Ya-Nan Deng1
11 State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy , No. 17, 3rd Section of People's South Road, Chengdu 610041 , People's Republic of China.
Abstract:
MicroRNAs (miRNAs) are one abundant class of small, endogenous non-coding RNAs, which regulate various biological processes by inhibiting expression of target genes. miRNAs have important functional roles in carcinogenesis and development of colorectal cancer (CRC), and emerging evidence has indicated the feasibility of miRNAs as robust cancer biomarkers. This review summarizes the progress in miRNA-related research, including study of its oncogene or tumour-suppressor roles and the advantages of miRNA biomarkers for CRC diagnosis, treatment and recurrence prediction. Along with analytical technique improvements in miRNA research, use of the emerging extracellular miRNAs is feasible for CRC diagnosis and prognosis.
Insights
MicroRNAs (miRNAs) are key regulators in colorectal cancer (CRC) development. Extracellular miRNAs show promise as biomarkers for CRC diagnosis and prognosis, aided by improved analytical techniques.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- MicroRNAs (miRNAs) are small, non-coding RNAs regulating gene expression.
- miRNAs play critical roles in colorectal cancer (CRC) development and progression.
- miRNAs are emerging as potential biomarkers for cancer detection and management.
Purpose of the Study:
- To review the current understanding of miRNA roles in CRC.
- To highlight the advantages of using miRNAs as biomarkers for CRC.
- To discuss the potential of extracellular miRNAs in CRC diagnosis and prognosis.
Main Methods:
- Literature review of miRNA research in colorectal cancer.
- Analysis of studies on oncogenic and tumor-suppressive roles of miRNAs.
- Evaluation of advancements in miRNA detection technologies.
Main Results:
- miRNAs are implicated in both the initiation and advancement of CRC.
- miRNA biomarkers offer advantages for CRC diagnosis, treatment selection, and recurrence monitoring.
- Extracellular miRNAs are increasingly recognized for their diagnostic and prognostic value in CRC.
Conclusions:
- miRNAs are significant players in colorectal cancer pathogenesis.
- miRNA-based biomarkers hold substantial promise for improving CRC patient outcomes.
- Further research and technological advancements will enhance the clinical utility of extracellular miRNAs in CRC.
Related Concept Videos
MicroRNAs
MicroRNAs
Emerging Adulthood
Nursing Diagnosis
The nursing diagnosis focuses on evidence-based...
Introduction Cardiac Emergencies
Documentation of Nursing Diagnosis
In some settings, data-driven computerized decision support systems are in place, allowing for more accurate nursing diagnoses. The database within one of these systems includes diagnostic labels defining characteristics, activities, and indicators for nursing. A nurse enters...

